In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 156 for your search:
Drug:  fludeoxyglucose F 18
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Diagnostic
Status: Closed
Age: 25 and over
Sponsor: Other
Protocol IDs: PEM-06-01, NIH Grant: 5 R44 CA103102-05, NCT00484614

2.

Phase: Phase III, Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 96-079, P30CA008748, MSKCC-96079, NCI-G97-1334, NCT00002930

3.

Phase: Phase III, Phase II
Type: Diagnostic
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: SP-11-0035/DX-FDG-001/21221, NCT00123760

4.

Phase: Phase III, Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000515329, UPCC-12199, UPCC-414500, NCT00194337

5.

Phase: Phase III
Type: Diagnostic, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: POLEM (ZonMW DO 945-11017), (ZonMW DO 945-11017), NCT00119899

6.

Phase: Phase III
Type: Diagnostic
Status: Closed
Age: no age specified
Sponsor: Other
Protocol IDs: CTRP024, NSC 92-2314-B-182A-084, NCT00146458

7.

Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: CTA-Control-088421, NCT00147472

8.

Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CTA-Control-092493, NCT00201942

9.

Phase: Phase III
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: P020907, NCT00236275

10.

Phase: Phase III
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NLG PET Study, NCT00286832

11.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 15 to 70
Sponsor: Other
Protocol IDs: EORTC-20051, GELA-H10, IIL-EORTC-20051, EUDRACT-2005-002765-37, EU-20657, NCT00433433

12.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other
Protocol IDs: CRUK-2007-006064-30, 2007-006064-30, CRUK-07/146, NCT00678327

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 75
Sponsor: Other
Protocol IDs: 03_DOG05_07, CHNT-RAPID, ISRCTN99811594, EU-20931, RAPID, NCT00943423

14.

Phase: Phase II, Phase I
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00600, CDR0000521453, ACRIN 6671, GOG-0233, GOG-0233-ACRIN 6671, U10CA027469, NCT00416455

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OSI3926g, ML20773, NCT00453362

16.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: EORTC-24051, 2006-002667-33, GSK-EORTC-24051, EUDRACT-2006-002667-33, NCT00498953

17.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000573917, NCCTG-N057K, N057K, NCT00553150

18.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00267, MGH-07-344, R01CA129371, CDR0000593717, PHS 398/2590, 8030, P30CA006516, 07-344, NCT00662506

19.

Phase: Phase II
Type: Diagnostic
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-97-C-0068

20.

Phase: Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 99-004, MSKCC-99004, NCI-G99-1619, NCT00004152

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 4 to 35
Sponsor: NCI
Protocol IDs: 020259, 02-C-0259, NCI-02-C-0259, NCT00047372, NCT00043979

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01438, 03-032, NCI-5917, CDR0000304738, MSKCC-03032, 5917, NCT00062374

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000362061, ACRIN-6668, RTOG-0235, NCT00083083

24.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SG015-0005, NCT00086333

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000426417, ACOSOG-Z4033, SRC1, NCT00109876
1     
New Search